Ketamine for Treatment-Resistant Depression Named A Top 10 Medical Innovation for 2017

According to Cleveland Clinic Innovations, a preeminent source for medical breakthroughs, ketamine for treatment-resistant depression will forever change patient care.

For 1/3 of depressed patients, traditional therapies and medications simply do not work. Ketamine, a drug commonly used for anesthesia, was studied by researchers at the National Institute of Health and found to bring overwhelmingly favorable results – with 70% of patients seeing relief from symptoms within 24 hours. These rapid timelines have raised eyebrows in the industry and led ketamine to be named among Cleveland Clinic Innovations’ Top 10 Medical Innovations for 2017.

Ketamine for Treatment-Resistant Depression: “It’s been reported that 70% of {ketamine infusion} patients felt the ease of symptoms in as little as one day.”

Thanks to ketamine, hope has never been higher in the medical community.